2025 United Kingdom Biobanking Market Revenue Opportunities Report
Description
The 2025 United Kingdom Biobanking Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Biobanking market in the United Kingdom include UK Biobank, Illumina, Oxford Nanopore, and Amazon Web Services (AWS). UK Biobank is the leading organization, housing over 15 million biological samples and extensive health data from half a million participants, supporting worldwide biomedical research with collaborations across academia, industry, and the NHS. Illumina launched a pilot proteomics program with UK Biobank in January 2025 to analyze 50,000 samples, enhancing biomarker discovery for diseases like cancer and cardiovascular conditions. Oxford Nanopore partnered with UK Biobank in late 2024 to create large-scale epigenetic datasets for disease research. Amazon Web Services supports data management for UK Biobank with cloud computing credits, fostering secure storage and AI analysis.
These companies drive the UK biobanking sector by providing advanced technologies and infrastructure essential for genomic, proteomic, and health data research. UK Biobank's new headquarters, funded by UK Research and Innovation with £127.6 million, is designed for faster sample processing and collaboration with biotech firms. Illumina and Oxford Nanopore contribute innovative sequencing and proteomics methods, accelerating personalized medicine research. AWS enables scalable data storage and computational power, boosting bioinformatics applications. This ecosystem integrates high-quality biospecimens, cutting-edge AI applications, and large-scale data analytics, supporting regenerative medicine, disease prevention, and therapeutic development in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biobanking Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Biobanking market in the United Kingdom include UK Biobank, Illumina, Oxford Nanopore, and Amazon Web Services (AWS). UK Biobank is the leading organization, housing over 15 million biological samples and extensive health data from half a million participants, supporting worldwide biomedical research with collaborations across academia, industry, and the NHS. Illumina launched a pilot proteomics program with UK Biobank in January 2025 to analyze 50,000 samples, enhancing biomarker discovery for diseases like cancer and cardiovascular conditions. Oxford Nanopore partnered with UK Biobank in late 2024 to create large-scale epigenetic datasets for disease research. Amazon Web Services supports data management for UK Biobank with cloud computing credits, fostering secure storage and AI analysis.
These companies drive the UK biobanking sector by providing advanced technologies and infrastructure essential for genomic, proteomic, and health data research. UK Biobank's new headquarters, funded by UK Research and Innovation with £127.6 million, is designed for faster sample processing and collaboration with biotech firms. Illumina and Oxford Nanopore contribute innovative sequencing and proteomics methods, accelerating personalized medicine research. AWS enables scalable data storage and computational power, boosting bioinformatics applications. This ecosystem integrates high-quality biospecimens, cutting-edge AI applications, and large-scale data analytics, supporting regenerative medicine, disease prevention, and therapeutic development in the UK.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
